What is the interpretation of an iron panel showing low serum iron, low transferrin saturation, normal ferritin, and normal‑high total iron‑binding capacity, and what management steps are recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Iron Panel Interpretation: Functional Iron Deficiency

Your iron panel shows functional iron deficiency—you have adequate iron stores (normal ferritin at 120.5 ng/mL) but insufficient iron availability for red blood cell production, as evidenced by low serum iron (45.2 µg/dL) and low transferrin saturation (15.42%).

Understanding Your Results

Your iron panel reveals a specific pattern that requires careful interpretation:

  • Low serum iron (45.2 µg/dL): Below the normal range of 50-212 µg/dL
  • Low transferrin saturation (15.42%): Below the critical threshold of 16-20%
  • Normal ferritin (120.5 ng/mL): Within normal range (10-291 ng/mL)
  • Normal TIBC (293.2 µg/dL): Within normal range (250-350 µg/dL)

This pattern indicates that while your body has stored iron (reflected by normal ferritin), it cannot mobilize this iron effectively for hemoglobin synthesis. A transferrin saturation below 16% is a sensitive marker of iron deficiency and indicates iron-deficient erythropoiesis 1.

Clinical Significance

The combination of low transferrin saturation with normal-to-elevated ferritin typically occurs in three scenarios:

1. Chronic Inflammation or Infection

Ferritin is an acute-phase reactant that rises during inflammation, potentially masking depleted iron stores 1. Your ferritin of 120.5 ng/mL could represent either:

  • True adequate stores without inflammation
  • Depleted stores masked by inflammation (since ferritin <100 ng/mL with transferrin saturation <16% suggests combined iron deficiency and anemia of chronic disease) 1

Check inflammatory markers (CRP, ESR) immediately to determine if inflammation is present 1. This is essential because the interpretation changes completely based on inflammatory status.

2. Functional Iron Deficiency

This occurs when iron stores exist but cannot be mobilized quickly enough to meet erythropoietic demands. Common in:

  • Chronic kidney disease 2
  • Chronic heart failure (40-70% prevalence) 2
  • Inflammatory bowel disease 1
  • Cancer-related anemia 3

3. Early Absolute Iron Deficiency

In the absence of inflammation, a ferritin between 30-100 ng/mL with transferrin saturation <16% suggests evolving iron deficiency 1. Your ferritin of 120.5 ng/mL is just above this range, but the low transferrin saturation remains concerning.

Diagnostic Algorithm

Step 1: Assess for inflammation

  • Order CRP and ESR
  • Review for chronic conditions (kidney disease, heart failure, inflammatory bowel disease, malignancy)

Step 2: Interpret based on inflammatory status

If NO inflammation (normal CRP/ESR):

  • Your pattern suggests early iron deficiency despite seemingly adequate ferritin
  • Ferritin <30 ng/mL defines absolute iron deficiency, but <45 ng/mL warrants investigation 2
  • Your ferritin of 120.5 ng/mL makes absolute deficiency less likely, but the low transferrin saturation indicates inadequate iron availability

If inflammation IS present:

  • Ferritin threshold shifts to 100 ng/mL for defining iron deficiency 1
  • Your ferritin of 120.5 ng/mL with transferrin saturation <16% suggests anemia of chronic disease 1
  • Consider measuring soluble transferrin receptor (sTfR) if available—elevated levels confirm true iron deficiency even with inflammation 1

Step 3: Check hemoglobin level

  • If anemic, this confirms iron-deficiency anemia requiring treatment
  • If not anemic, this represents non-anemic iron deficiency, which may still warrant investigation depending on symptoms and risk factors 2

Management Recommendations

Immediate Actions:

  1. Obtain complete blood count to assess for anemia (hemoglobin <130 g/L in men, <120 g/L in non-pregnant women) 2

  2. Check inflammatory markers (CRP, ESR) to guide interpretation 1

  3. Evaluate for underlying causes:

    • GI blood loss: Most common cause in men and postmenopausal women. Consider upper and lower endoscopy if anemic, especially with hemoglobin <110 g/L in men or <100 g/L in women 2
    • Menstrual blood loss: In premenopausal women
    • Malabsorption: Celiac disease, H. pylori infection, inflammatory bowel disease 4
    • Chronic kidney disease: Check GFR if not recently done 2
    • Dietary insufficiency: Assess iron intake 4

Iron Replacement Strategy:

If anemic or symptomatic:

  • First-line: Oral iron supplementation 2, 4

    • Ferrous sulfate, ferrous fumarate, or ferrous gluconate are reasonable first choices 4
    • Take on empty stomach for better absorption, or with meals if not tolerated 4
    • Adding 500 mg vitamin C improves absorption 4
    • Common side effects: nausea, abdominal pain, constipation 4

  • Consider intravenous iron if: 2, 4

    • Oral iron not tolerated
    • Oral iron ineffective after adequate trial
    • Severe iron deficiency
    • Malabsorption conditions present
    • Chronic kidney disease on dialysis 2
    • Inflammatory bowel disease with active inflammation 1

Treatment Targets:

  • Goal transferrin saturation: ≥20% 2, 1
  • Monitor response with repeat iron studies in 4-8 weeks
  • In chronic kidney disease, maintain ferritin 100-200 µg/L (predialysis/peritoneal dialysis) or 200-500 µg/L (hemodialysis) with transferrin saturation >20% 2

Critical Pitfalls to Avoid:

  1. Do not dismiss low transferrin saturation because ferritin is normal—transferrin saturation <16% indicates inadequate iron availability regardless of ferritin level 1

  2. Do not skip inflammatory marker testing—ferritin interpretation is completely different with versus without inflammation 1

  3. Do not delay GI evaluation in unexplained iron deficiency—particularly in men and postmenopausal women, as colorectal cancer risk is significant 2

  4. Do not over-supplement iron—transferrin saturation >800 µg/L is toxic 1

  5. In chronic disease states, do not use standard ferritin cutoffs—thresholds shift upward with inflammation 2, 1

References

3
Guideline

cancer- and chemotherapy-induced anemia.

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

Related Questions

What does an iron panel showing total iron‑binding capacity 368 µg/dL, ferritin 15 µg/L, serum iron 128 µg/dL, and transferrin saturation 35% indicate, and how should it be managed?
My iron studies show total iron 70 mcg/dL (reference 40‑190), total iron‑binding capacity 364 mcg/dL (reference 250‑450), transferrin saturation 19 % (reference 16‑45), and ferritin 15 ng/mL (reference 16‑154). What does this indicate and what should I do?
Should my patient continue iron supplementation given a serum iron of 36 µg/dL, total iron‑binding capacity of 344 µg/dL, and transferrin saturation of 11%?
What is the significance of a high serum iron level with low transferrin saturation and low ferritin, and how should it be evaluated and managed?
In an anemia evaluation, can ferritin be normal while serum iron and transferrin saturation are low?
In a 29‑year‑old woman with a typical migraine presentation (left‑sided throbbing headache, photophobia, phonophobia, nausea, vomiting) and no red‑flag findings, how should I document the medical decision‑making to justify that an emergent head CT is not required?
What are the causes of ischemic colitis in a 50‑year‑old woman with an intrauterine device (IUD) who is not taking any other medications?
What defines excessive menstrual bleeding (menorrhagia) in a 14‑year‑old adolescent?
Is administering 35 units of insulin glargine (Lantus) at bedtime considered standard practice?
In a patient who developed new headache, blurry vision and bilateral peripheral visual‑field loss two days before a cardiac arrest (with a limited head CT ordered for headache/neuro deficit) and then suffered a prolonged hypoxic‑ischemic injury after the arrest, what is the most likely cause of the pre‑arrest visual deficit, and is the current peripheral‑field loss a continuation of that pre‑arrest lesion, a result of the post‑arrest anoxic injury, or a combination of both? Additionally, was a brain MRI performed after the limited CT?
Which specialist should evaluate two girls, aged 10 and 8, who are urinating on themselves while playing video games?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.